These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 29489069

  • 1. Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy.
    Liu SY, Chen J, Li YF.
    J Diabetes Investig; 2018 Sep; 9(5):1182-1188. PubMed ID: 29489069
    [Abstract] [Full Text] [Related]

  • 2. The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients.
    Ates I, Ozkayar N, Akyel F, Topcuoglu C, Akyel S, Barça AN, Dede F.
    BMC Nephrol; 2014 Oct 01; 15():159. PubMed ID: 25273526
    [Abstract] [Full Text] [Related]

  • 3. The Relationship between Serum TWEAK Levels and Carotid Intima-media Thickness in Patients with Fabry Disease.
    Turkmen K, Baloglu I, Aykut T, Demir S, Altın E, Akguzel ZA, Kocabas M, Yerlikaya FH.
    Saudi J Kidney Dis Transpl; 2023 Sep 01; 34(5):406-415. PubMed ID: 38995299
    [Abstract] [Full Text] [Related]

  • 4. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
    Fan WC, Huang CC, Yang YY, Lin A, Lee KC, Hsieh YC, Fung CP, Hsu HC, Hou MC, Lin HC.
    J Microbiol Immunol Infect; 2017 Dec 01; 50(6):905-914. PubMed ID: 26872435
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of soluble TNF-like weak inducer of apoptosis (sTWEAK) levels to predict preeclampsia in early weeks of pregnancy.
    Shahid S, Khalid E, Fatima SS, Khan GM.
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar 01; 234():165-170. PubMed ID: 30708268
    [Abstract] [Full Text] [Related]

  • 6. Serum sTWEAK levels in chronic periodontitis and type 2 diabetes mellitus.
    Acharya AB, Chandrashekar A, Acharya S, Shettar L, Thakur S.
    Diabetes Metab Syndr; 2019 Mar 01; 13(2):1609-1613. PubMed ID: 31336529
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of urinary tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in immunoglobulin A nephropathy
.
    Kim JS, Jeong KH.
    Clin Nephrol; 2020 Feb 01; 93(2):99-105. PubMed ID: 31829928
    [Abstract] [Full Text] [Related]

  • 8. Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation.
    Yilmaz MI, Carrero JJ, Martín-Ventura JL, Sonmez A, Saglam M, Celik T, Yaman H, Yenicesu M, Eyileten T, Moreno JA, Egido J, Blanco-Colio LM.
    Clin J Am Soc Nephrol; 2010 Jul 01; 5(7):1174-81. PubMed ID: 20430947
    [Abstract] [Full Text] [Related]

  • 9. Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance.
    Tang B, Zhong Z, Qiu Z, Wu HP, Hu JY, Ma JP, Wu JP.
    Clin Chim Acta; 2019 Aug 01; 495():227-232. PubMed ID: 31009601
    [Abstract] [Full Text] [Related]

  • 10. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.
    Fernández-Laso V, Méndez-Barbero N, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM.
    Atherosclerosis; 2017 May 01; 260():130-137. PubMed ID: 28390291
    [Abstract] [Full Text] [Related]

  • 11. The association between interleukin-19 concentration and diabetic nephropathy.
    Li L, Jiang XG, Hu JY, Yu ZQ, Xu JY, Liu F, Zhao GC, Zhang L, Gu HM, Zhang SJ, Meng J.
    BMC Nephrol; 2017 Feb 15; 18(1):65. PubMed ID: 28201997
    [Abstract] [Full Text] [Related]

  • 12. Inverse Relationship between Plasma Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Carotid Intima-Media Thickness among Patients Undergoing Hemodialysis and Peritoneal Dialysis.
    Shi X, Qiu B, Shen H, Feng S, Fu J.
    Cardiorenal Med; 2020 Feb 15; 10(3):137-144. PubMed ID: 32126565
    [Abstract] [Full Text] [Related]

  • 13. Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients.
    Asil M, Dertli R.
    Medicine (Baltimore); 2016 Sep 15; 95(37):e4763. PubMed ID: 27631226
    [Abstract] [Full Text] [Related]

  • 14. Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.
    Carrero JJ, Ortiz A, Qureshi AR, Martín-Ventura JL, Bárány P, Heimbürger O, Marrón B, Metry G, Snaedal S, Lindholm B, Egido J, Stenvinkel P, Blanco-Colio LM.
    Clin J Am Soc Nephrol; 2009 Jan 15; 4(1):110-8. PubMed ID: 18945991
    [Abstract] [Full Text] [Related]

  • 15. Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.
    Dirajlal-Fargo S, Sattar A, Kulkarni M, Funderburg N, McComsey GA.
    HIV Clin Trials; 2017 Jul 15; 18(4):156-163. PubMed ID: 28828963
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study.
    Llauradó G, González-Clemente JM, Maymó-Masip E, Subías D, Vendrell J, Chacón MR.
    PLoS One; 2012 Jul 15; 7(8):e43919. PubMed ID: 22937125
    [Abstract] [Full Text] [Related]

  • 17. Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance.
    Dereke J, Nilsson J, Nilsson C, Strevens H, Landin-Olsson M, Hillman M.
    PLoS One; 2019 Jul 15; 14(5):e0216728. PubMed ID: 31071174
    [Abstract] [Full Text] [Related]

  • 18. Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study.
    Melin EO, Dereke J, Hillman M.
    BMC Psychiatry; 2020 Dec 01; 20(1):574. PubMed ID: 33261587
    [Abstract] [Full Text] [Related]

  • 19. Serum cathelicidin as a marker for diabetic nephropathy in patients with type 1 diabetes.
    El-Ashmawy HM, Ahmed AM.
    Diabetes Metab Res Rev; 2018 Nov 01; 34(8):e3057. PubMed ID: 30091508
    [Abstract] [Full Text] [Related]

  • 20. The Diagnostic Value of sTWEAK in Acute Ischemic Stroke.
    Comertpay E, Vural S, Eroğlu O, Dindar Badem N, Karadeniz Bilgili Y, Coşkun F.
    Balkan Med J; 2020 Oct 23; 37(6):336-340. PubMed ID: 32856885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.